Cargando…
Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective
ABSTRACT: Despite the development of novel pharmacological treatments, cardiovascular disease morbidity and mortality remain high indicating an unmet clinical need. Viral gene therapy enables targeted delivery of therapeutic transgenes and represents an attractive platform for tackling acquired and...
Autores principales: | JT, Schwartze, M, Havenga, WAM, Bakker, AC, Bradshaw, SA, Nicklin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126699/ https://www.ncbi.nlm.nih.gov/pubmed/35606652 http://dx.doi.org/10.1007/s00109-022-02208-0 |
Ejemplares similares
-
Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
por: Coughlan, Lynda, et al.
Publicado: (2010) -
Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022) -
Updates and New Perspectives on Adenoviral Gene Therapy and Vaccine Vectors
por: Dobner, Thomas, et al.
Publicado: (2023) -
Adenoviral Vectors for Hemophilia Gene Therapy
por: Brunetti-Pierri, N, et al.
Publicado: (2013) -
Factors influencing adenoviral gene transfer
por: Huizinga, TWJ, et al.
Publicado: (2001)